<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="77292">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01983345</url>
  </required_header>
  <id_info>
    <org_study_id>2013-A00385-40</org_study_id>
    <nct_id>NCT01983345</nct_id>
  </id_info>
  <brief_title>Prenatal Surgical Repair of Fetal Myelomeningocele</brief_title>
  <acronym>PRIUM</acronym>
  <official_title>Prenatal Surgical Repair of Fetal Myelomeningocele</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The open surgical repair of myelomeningoceles before 26 weeks gestational age provides a
      correction of the anomaly of Chiarri, reduces the incidence of ventriculomegaly (defined as
      a measure of the ventricles at the crossroads ≥ 10 mm), and get a lower of injury than one
      corresponding to the anatomical defect (as defined by the last upper normal vertebra before
      the defect).

      The purpose of this study is to introduce in France an innovative technique for prenatal
      repair of myelomeningocele until now developed only on the American continent.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Spina bifida (SB) represents one of the most severe congenital malformation of the central
      nervous system and amenable to prenatal diagnosis. In the past 20 years, prenatal repair of
      SB has become an established technique.

      The PRIUM study will include 10 cases of fetuses with prenatal diagnosis of SB and for whom
      the maternal willing will be to continue the pregnancy.  A surgical prenatal repair of the
      defect will be planed at 19-25+6 weeks gestation following maternal laparotomy and
      hysterotomy under maternal general anesthesia. The delivery will be planed at 36 weeks'.
      Postnatal evaluation of the neonates will be scheduled  at birth, 1 month and 12 months od
      age. Those data will be matched to controls who have underwent a conventional postnatal
      repair of the SB
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Arnold Chiari anomaly at birth</measure>
    <time_frame>Day 0</time_frame>
    <safety_issue>No</safety_issue>
    <description>the existence of an Arnold Chiari anomaly at birth</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Defect</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>the level difference between the observed level of injury and the anatomical level of the defect (as defined by the last normal upper vertebra before the defect)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Foetus With Myelomeningocele</condition>
  <arm_group>
    <arm_group_label>no surgery</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>open surgical repair</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>open surgical repair of myelomeningocele before 26 SA</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>prenatal surgical repair of fetal myelomeningocele</intervention_name>
    <description>open surgical repair of myelomeningocele before 26 weeks gestational age</description>
    <arm_group_label>open surgical repair</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient of majority age, with an assumption by health insurance, understanding and
             speaking French

          -  A term between 19 and 25 +6 weeks gestational age

          -  Single-Pregnancy

          -  Normal fetal karyotype

          -  Myelomeningocele with higher-level defect between S1 and T1

          -  Placenta not low-inserted or not covering

          -  Fault-isolated ultrasound reference

        Exclusion Criteria:

          -  Age under 18 years

          -  Patient foreigner who understands not French

          -  Multiple Pregnancy

          -  Low Placenta inserted or covering

          -  Severe kyphosis

          -  Placental abruption

          -  Fetal malformation unrelated to the existence of myelomeningocele (the existence of a
             malposition of one or both feet do not represent an exclusion criterion)

          -  Increased risk of preterm birth: a history of preterm delivery before 37 weeks
             gestational age, cervical length &lt;26 mm before 26 weeks gestational age

          -  Bleeding active between 20 and 26 weeks gestational age

          -  Maternal obesity with BMI&gt; 35

          -  History of uterine surgery involving the anterior surface of the uterus

          -  Maternal contradiction in surgery or general anesthesia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel ZERAH, PUPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Marie Jouannic, PUPH</last_name>
    <phone>0033144735228</phone>
    <email>laurence.lecomte@nck.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laurence Lecomte, PhD</last_name>
    <phone>0033158413545</phone>
    <email>laurence.lecomte@nck.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital Armand Trousseau, APHP</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Marie JOUANNIC, PUPH</last_name>
      <phone>0033144735228</phone>
      <email>jean-marie.jouannic@trs.aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Laurence lecomte, PhD</last_name>
      <phone>0033158413545</phone>
      <email>laurence.lecomte@nck.aphp.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 7, 2013</lastchanged_date>
  <firstreceived_date>November 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myelomeningocele</keyword>
  <keyword>Arnold Chiari malformation</keyword>
  <keyword>Spina bifida</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Meningomyelocele</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
